248 related articles for article (PubMed ID: 24711523)
1. Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor.
Fu Z; Zhao L; Aylor KW; Carey RM; Barrett EJ; Liu Z
Hypertension; 2014 Jun; 63(6):1219-27. PubMed ID: 24711523
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo.
Chai W; Wang W; Dong Z; Cao W; Liu Z
Diabetes; 2011 Nov; 60(11):2939-46. PubMed ID: 21896931
[TBL] [Abstract][Full Text] [Related]
3. The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7).
Muñoz MC; Giani JF; Burghi V; Mayer MA; Carranza A; Taira CA; Dominici FP
Regul Pept; 2012 Aug; 177(1-3):1-11. PubMed ID: 22561450
[TBL] [Abstract][Full Text] [Related]
4. Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery.
Zhao L; Chai W; Fu Z; Dong Z; Aylor KW; Barrett EJ; Cao W; Liu Z
Circ Res; 2013 Apr; 112(9):1263-71. PubMed ID: 23459195
[TBL] [Abstract][Full Text] [Related]
5. ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.
Prasannarong M; Santos FR; Henriksen EJ
Biochem Biophys Res Commun; 2012 Sep; 426(3):369-73. PubMed ID: 22960175
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine recruits muscle microvasculature and enhances insulin action in rats.
Fu Z; Zhao L; Chai W; Dong Z; Cao W; Liu Z
J Physiol; 2013 Oct; 591(20):5235-49. PubMed ID: 23798495
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas.
Muñoz MC; Giani JF; Dominici FP
Regul Pept; 2010 Apr; 161(1-3):1-7. PubMed ID: 20188769
[TBL] [Abstract][Full Text] [Related]
8. Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment.
Wang N; Chai W; Zhao L; Tao L; Cao W; Liu Z
Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E538-45. PubMed ID: 23299501
[TBL] [Abstract][Full Text] [Related]
9. Vasodilatory Actions of Glucagon-Like Peptide 1 Are Preserved in Skeletal and Cardiac Muscle Microvasculature but Not in Conduit Artery in Obese Humans With Vascular Insulin Resistance.
Wang N; Tan AWK; Jahn LA; Hartline L; Patrie JT; Lin S; Barrett EJ; Aylor KW; Liu Z
Diabetes Care; 2020 Mar; 43(3):634-642. PubMed ID: 31888883
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase A mediates glucagon-like peptide 1-induced nitric oxide production and muscle microvascular recruitment.
Dong Z; Chai W; Wang W; Zhao L; Fu Z; Cao W; Liu Z
Am J Physiol Endocrinol Metab; 2013 Jan; 304(2):E222-8. PubMed ID: 23193054
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.
Giani JF; Gironacci MM; Muñoz MC; Peña C; Turyn D; Dominici FP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1154-63. PubMed ID: 17496209
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats.
Chai W; Fu Z; Aylor KW; Barrett EJ; Liu Z
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E640-8. PubMed ID: 27436611
[TBL] [Abstract][Full Text] [Related]
13. Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle.
Premilovac D; Attrill E; Rattigan S; Richards SM; Kim J; Keske MA
Cardiovasc Res; 2019 Mar; 115(3):590-601. PubMed ID: 30192915
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol recruits rat muscle microvasculature via a nitric oxide-dependent mechanism that is blocked by TNFα.
Wang N; Ko SH; Chai W; Li G; Barrett EJ; Tao L; Cao W; Liu Z
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E195-201. PubMed ID: 20978231
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Mas1 Receptor-Mediated Signaling in the Vascular Endothelium.
Hoffmann BR; Stodola TJ; Wagner JR; Didier DN; Exner EC; Lombard JH; Greene AS
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):433-445. PubMed ID: 28082260
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathways.
Li Y; Cao Y; Zeng Z; Liang M; Xue Y; Xi C; Zhou M; Jiang W
Sci Rep; 2015 Feb; 5():8209. PubMed ID: 25644821
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-(1-7) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries.
Durand MJ; Raffai G; Weinberg BD; Lombard JH
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1024-33. PubMed ID: 20656887
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism.
Chai W; Dong Z; Wang N; Wang W; Tao L; Cao W; Liu Z
Diabetes; 2012 Apr; 61(4):888-96. PubMed ID: 22357961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
